Subscribe for great stories in your community!
UGI Corp., like many United States firms in the post-COVID era, is seeking to welcome employees back on site with better-appointed office spaces…
The Food and Drug Administration has awarded King of Prussia-based CSL Behring marketing approval for Hemgenix, the first hemophilia B gene therapy to treat…
CSL Behring has decided to sublease its building at 500 N. Gulph Road in King of Prussia three years after it moved into the 100…
The annual rankings from Forbes and Statista, the world-leading statistics portal and industry ranking provider, are based on an independent survey of approximately 60…
“Our collective hope shines a light on the progress made and challenges ahead,” CSL Behring Limited CEO and Managing Director Paul Perreault said in a…
At the celebratory event, presented by global biotherapies leader CSL Behring, Uplifting Athletes awarded $180,000 in research grants to nine promising young investigative rare…
For the fourth year in a row, CSL Limited, the parent company of King of Prussia-based CSL Behring, has been named one of the…
King of Prussia-based CSL Behring provided an update earlier this week on its multiple efforts – both independent and in collaborations – to battle COVID-19…
A group of companies including King of Prussia-based CSL Behring are currently testing an experimental treatment for COVID-19 derived from the convalescent plasma…
King of Prussia-based CSL Behring is using an AI forecasting system developed over the span of four months utilizing data from the previous five…
King of Prussia-based CSL Behring has joined forces with several other biopharmaceutical companies to develop a potential plasma-derived therapy to treat COVID-19…
Headquartered in King of Prussia, CSL Behring, a company with 26,000+ employees in 30 countries, is a global biotechnology leader offering the broadest range…
After 60 years, the King of Prussia business park has been rechristened with a name that evokes vitality, while maintaining a bit of mystery concerning…
CSL Behring is taking its workplace wellness initiatives to a whole new level by providing the American Heart Association’s (AHA) Hands-Only™ cardiopulmonary resuscitation…
King of Prussia’s CSL Behring has received more positive news for its autoimmune and inflammatory disease disorder drug Privigen, as the FDA has approved…
King of Prussia’s biotherapeutics company CSL Behring is acquiring Calimmune, a clinical-stage biotechnology company, for $91 million, writes Linda Loyd for Philly.com…
Australia’s CSL Limited along with its CSL Behring business unit in King of Prussia has acquired a majority stake in Chinese plasma company Wuhan…
Before we send you to this site, please subscribe to our daily newsletter.